Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Illumina
ILMN
|
+$779M |
| 2 |
QuantumScape
QS
|
+$754M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$535M |
| 4 |
Booking.com
BKNG
|
+$399M |
| 5 |
L3Harris
LHX
|
+$322M |
Top Sells
| 1 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
+$476M |
| 2 |
Intuitive Surgical
ISRG
|
+$469M |
| 3 |
Home Depot
HD
|
+$454M |
| 4 |
Intel
INTC
|
+$359M |
| 5 |
Salesforce
CRM
|
+$350M |
Sector Composition
| 1 | Technology | 31.01% |
| 2 | Healthcare | 19.61% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Financials | 9.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Host Hotels & Resorts
HST
$12.1B
| $43M | 0.02% |
2,938,112
+2,330,107
| +383% | +$34.1M |
|
577
Invesco QQQ Trust
QQQ
$369B
| $42.7M | 0.02% |
136,136
+4,455
| +3% | +$1.4M |
|
578
MarketAxess Holdings
MKTX
$6.9B
| $42.7M | 0.02% |
74,811
-18,097
| -19% | -$10.3M |
|
579
Pinduoduo
PDD
$177B
| $42.6M | 0.02% |
240,019
-146,165
| -38% | -$26M |
|
580
Bank of Hawaii
BOH
$2.7B
| $42.6M | 0.02% |
556,356
-94,364
| -15% | -$7.23M |
|
581
Sabra Healthcare REIT
SBRA
$4.54B
| $42.6M | 0.02% |
2,450,564
+385,110
| +19% | +$6.69M |
|
582
Agilent Technologies
A
$35.2B
| $42.4M | 0.02% |
357,516
-60,002
| -14% | -$7.11M |
|
583
CryoPort
CYRX
$480M
| $42.3M | 0.02% |
963,414
-117,726
| -11% | -$5.17M |
|
584
AstraZeneca
AZN
$251B
| $42.1M | 0.02% |
841,212
+235,054
| +39% | +$11.8M |
|
585
Fabrinet
FN
$13.3B
| $42M | 0.02% |
541,422
+46,557
| +9% | +$3.61M |
|
|
ACCD
586
DELISTED
Accolade, Inc. Common Stock
ACCD
| $41.8M | 0.02% |
+962,010
| New | +$41.8M |
|
587
Exxon Mobil
XOM
$480B
| $41.8M | 0.02% |
1,013,156
-67,516
| -6% | -$2.78M |
|
588
Insight Enterprises
NSIT
$3.96B
| $41.6M | 0.02% |
546,223
+293,099
| +116% | +$22.3M |
|
589
Mondelez International
MDLZ
$80.6B
| $41.3M | 0.02% |
707,312
-3,470
| -0.5% | -$203K |
|
590
Evercore
EVR
$12.8B
| $40.8M | 0.02% |
372,161
-165,600
| -31% | -$18.2M |
|
591
Henry Schein
HSIC
$8.17B
| $40.8M | 0.02% |
609,692
+372,937
| +158% | +$24.9M |
|
592
TransUnion
TRU
$17.5B
| $40.5M | 0.02% |
407,958
-58,320
| -13% | -$5.79M |
|
593
C4 Therapeutics
CCCC
$188M
| $40.4M | 0.02% |
+1,297,609
| New | +$40.4M |
|
|
SRC
594
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $40.3M | 0.02% |
1,003,756
-77,131
| -7% | -$3.1M |
|
595
Certara
CERT
$1.65B
| $40.1M | 0.02% |
+1,188,508
| New | +$40.1M |
|
596
4D Molecular Therapeutics
FDMT
$324M
| $39.9M | 0.02% |
+1,021,911
| New | +$39.9M |
|
597
Harmony Biosciences
HRMY
$1.91B
| $39.6M | 0.02% |
1,094,449
+219,540
| +25% | +$7.94M |
|
|
HSKA
598
DELISTED
Heska Corp
HSKA
| $39.6M | 0.02% |
271,540
-115,632
| -30% | -$16.8M |
|
599
Criteo
CRTO
$1.18B
| $39.2M | 0.02% |
1,914,675
-20,885
| -1% | -$428K |
|
600
Ameris Bancorp
ABCB
$5.07B
| $39M | 0.02% |
+1,024,995
| New | +$39M |
|